Inter-Individual Variability in Xenobiotic-Metabolizing Enzymes: Implications for Human Aging and Longevity

Area of Science:

• Genetics
• Aging Research
• Toxicology

Background:

• Xenobiotic-metabolizing enzymes (XME) are crucial for detoxifying harmful compounds.
• Aging impairs XME function, increasing susceptibility to toxins and age-related diseases.
• Genetic variability in XME genes influences individual responses to xenobiotics and disease risk.

Purpose of the Study:

• To investigate the hypothesis that variability in XME genes affects an individual's likelihood of achieving longevity.
• To identify specific XME gene variants associated with exceptional lifespan.

Main Methods:

• Screened 1112 individuals (aged 20-108 years) for 35 variants in 23 XME genes.
• Analyzed the association between identified genetic variants and longevity phenotypes.
• Focused on the impact of variants in CYP2B6, CYP3A5, COMT, and ABCC2 genes.

Main Results:

• Identified four specific XME gene variants (CYP2B6/rs3745274, CYP3A5/rs776746, COMT/rs4680, ABCC2/rs2273697) that significantly impacted longevity.
• Observed the most pronounced effects in the 65-89 age group, a period with high incidence of age-related diseases.
• Found that XME gene variability accounted for 7.7% of the probability of surviving beyond 89 years.

Conclusions:

• XME genes play a significant role in mediating gene-environment interactions that influence the attainment of advanced age.
• Genetic variability in XME genes represents a novel factor in determining longevity and healthy aging.
• These findings suggest XME genes as potential targets for future research into the genetic determinants of age-related traits and longevity.